Break Through Treatment in Myasthenia Gravis (MG)

Breakthrough NEW TREATMENT  for Myasthenia Gravis (MG) Clinical Research Formulated &  Released by Chris Constantine   ACP New breakthrough treatment for Myasthenia Gravis (MG) It is disorder that we rarely hear about, some very famous people who suffered from Myasthenia Gravis are David Nivine, Aristotle Onassis, Sir Lawrence Olivier, Phil Silvers (actor- Sgt Bilko) Myasthenia gravis occurs in all ethnic groups and both genders. statistically it most commonly affects young adult women (under 40) and older men (over 60), but it can occur at any age and to anyone The research and new treatment for MG is formulated by Mr. Chris Constantine who has been a clinical psychotherapist since 1988, in his 21 years of practice he is also a clinical researcher and lecturer of Clinical Psychotherapy, discovering and introducing treatments for various psychological and addictive disorders as well as Neurological disorders such as Myasthenia Gravis  Myasthenia Gravis (MG), MG comes from Latin & Greek, meaning ‘grave muscle weakness’. MG is a rare condition affecting the nerves that supply the muscles around the body, which leaves them weekend, its precise cause is unknown. The research below shows how Mr. Chris Constantine treatment for Myasthenia Gravis as a breakthrough and the most effective treatment today. Lecturer of Clinical Psychotherapy at ACP Academy of Clinical Psychotherapy & Harley Street Academy & Constantine Self Improvement Centre (CSIC). MYASTHENIA GRAVIS (MG)   Research study by Mr. Chris Constantine Mr. Chris Constantine / HSAP Constantine Treatment of MG Founded & Formulated treatment by Mr. Chris Constantine Research Co-Ordinator, Dr. Rehan Abbas Esar.  Neurologist   Research Director Professor Tarique – Professor of Nuerology Myasthenia Gravis comes from the Greek & Latin words meaning grave muscle weakness. It is an autoimmune, chronic neuromuscular disease that manifests itself by varying weakness of the voluntary muscles of the body. It is one of the best-understood autoimmune diseases. Myasthenia has been known to occur since the 19th century. Myasthenia occurs in all races, sexes and at any age. It is more common in the young females and older men. It can be congenital (at birth) or acquired. MG is not contagious It can affect any voluntary muscle of the body and the muscle weakness is not always symmetrical i.e. one limb may be affected more than the other or one eyelid would be more drooping than the other etcetera. Certain muscles are more involved than the others like the ones, which control eye movements, chewing, swallowing, coughing, limbs and breathing muscles. The mildest form of the disease is one in which ocular (eye) muscles are involved and in its severest form the breathing muscles are affected and patient needs to be hospitalized. MG is disease of the neuromuscular junction, a gap between the nerve ending and muscle fibre. In this disease acetylcholine that is released from the nerve ending cannot be attached to the receptors sites on the muscle fibre and when enough receptor sites have not been activated by acetylcholine (ACH), contraction of muscle cannot take place. In MG there is a reduction of these receptor sites. The reduction of receptor sites is caused by antibodies that either destroys or blocks these sites at the neuromuscular junction antibody are proteins that play an important role in our immune system. The antibodies are normally directed at antigens (foreign bodies) that attack the body like bacteria and viruses. The antibody’s help protect the body against foreign intruders. Unlike in MG, the immune system produces antibodies against the receptor sites on the N-M junction. These receptor sites are more rapidly destroyed than can be replaced and so as a result there is muscular weakness. Diagnosis of  MG depends on the physician’s knowledge of MG and expertise. In evaluating the weakness the physician will carry out a neurological examination. There are some tests, which have been diagnostic for MG. The edrophonium ( TENSILON ) test is done by injecting the chemical into the vein and seeing the result. Antibodies can also be measured in the blood (ACH-Receptor antibody test). Electromyography (EMG) studies include repetitive electrical stimulation of nerves of the patient. Apart from this X-Ray chest, MRI or CT scan be done to exclude any abnormally large mass in the chest and to rule out malignancy (THYMOMA). Thymoma is tumor of the thymus gland, which may become enlarged in MG. A four-week Research based project was conducted in Pakistan (South-East Asia) on patients of MG , by The Harley Street Academy of Psychotherapy (HSAP), the HSAP conducted its project in Pakistan at Pakistan Myasthenic Welfare Organization (PMWO) in Islamabad and Lahore. The patients were all from educated backgrounds and of both sexes and all ages. The patients selected for the project were all patients of a top Neurologist, Prof. Dr. M.Tariq, Head of Department of Neurology, Pakistan Institute of Medical Sciences, Islamabad. The project was held under supervision of the Secretary General PMWO, Mr. Khalid M. Zia, in the office of the organization. The therapies applied were those introduced and used successfully on patients in the U.K by Dean. Chris Constantine Consultant Psy. and Dean HSAP, London. The patients were continuously monitored by their families. Two patients were selected for EMG, carried out by Sr. Resident PIMS, Dr. Azhar Saeed and by Asst. Prof. Dr. M. Irshad, PIMS, Islamabad. Both also belonged to the Neurology department of  PIMS, Islamabad. The specific treatments used in the above treatments in MG patients is Constantine HSAP Psychomyastheniogarvis treatment &   HSAP Psychoneuromotorrepair  Treatment, both are housed under  Constantine  Psychoneurologia I Professor Tarique head of Neurology can categorically confirm that Mr. Chris Constantine new treatment in MG is successful and clinically valid, a major breakthrough in the treatment of MG sufferers. I have noted an immense benefit greater than any other treatment presently available to MG sufferers, Mr. Constantine’s achievement is astonishing and very welcoming. I further found Mr. Constantine’s gesture to allow  The Pakistan Myasthenic Welfare Organisation Islamabad (PMWO) free use of his treatment to be honourable  and commendable. I Dr. Rehan Abbas Esar, Neurologist, have found that all patients had benefited immensely from Mr. C. Constantine’s  Psychoneurologia treatments, I have noted patients mental and physical improvements and improvements in quality of life. Circular negative thinking, stress, worry lack of sleep and of relaxation acts as a trigger. An MG sufferer finds him/herself in a vicious circle, the stressors that are apparent from simply being inflicted by MG is the trigger to MG itself, learning to manage stressors and diversion from the illness itself is the key to being free from MG and there is no reason why a sufferer should be free from the symptomata of MG for life by using Mr. C. Constantine’s treatment. Mr. Chris Constantine HSAP Psychotherapy / Psychoneurologia was  conducted by, Dr. Rehan Abbas Esar, Neurologist. & Post Graduate Student of Mr. C. Constantine Research & Project Co-Ordinator for Mr. Chris ConstantineHSAP For full details on research study visit website  www.csic.org.uk For treatment contact -   Mr. Constantine offers his treatments for MG Contact Mr. C. Constantine Email: csic@live.co.uk www.csic@org.uk


# # #

CSIC (Constantine Self Improvement Centre) ACP Academy of Clinical Psychotherapy Offering training in Clinical Psychotherapy & Clinical Research

Name*:
E-mail*:
Captcha*:
Text*: